Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Erica Rogers
AddedMar 31, 2024
UpdatedMay 31, 2026
Erica Rogers

Erica Rogers

CEO, Silk Road Medical

Crunchbase

Erica Rogers's Career

Silk Road Medical
Silk Road Medical

Sunnyvale, CA, US

CEO· C-Suite · Management
HistoSonics
HistoSonics

Ann Arbor, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Erica Rogers's Career

Silk Road Medical
Silk Road Medical
Acquired02007Sunnyvale, CA, US
CEO· C-Suite · Management

Leadership at Silk Road Medical

Bess WeathermanBess WeathermanBoard Member
Jack W. LasersohnJack W. LasersohnBoard Member
Kevin BallingerKevin BallingerBoard Member
Don ZurbayDon ZurbayBoard Member

Similar to Silk Road Medical

Elixir MedicalElixir MedicalSunnyvale, CA, USMedical Devicesest. 2004Elixir MedicalSunnyvale, CA, US · est. 2004

Sunnyvale-based Elixir Medical Corp. develops advanced medical devices and pharmaceuticals for effective cardiovascular treatment.

Series A · $5.3M75
EndologixEndologixIrvine, CA, USMedical Devicesest. 1992EndologixIrvine, CA, US · est. 1992

Endologix, Inc.: Global developer and manufacturer of minimally invasive aortic treatments.

Public · $210.6M750
Intuitive SurgicalIntuitive SurgicalSunnyvale, CA, USMedical Devices, Surgical Systemsest. 1995Intuitive SurgicalSunnyvale, CA, US · est. 1995

Intuitive Surgical, Inc.: A global American corporation designing, manufacturing, and marketing advanced surgical systems.

Public12.1k
Traverse VascularTraverse VascularSolana Beach, CA, USMedical Devicesest. 2019Traverse VascularSolana Beach, CA, US · est. 2019

Traverse Vascular: Innovating chronic total occlusions treatment with breakthrough medical devices since 2019.

Pre-Seed · $1.1M1
HistoSonics
HistoSonics
Series B$226.8M1382009Ann Arbor, MI, US
Board Member· Board

Leadership at HistoSonics

Michael BunkerMichael BunkerBoard Member
Gerry BrunkGerry BrunkBoard Member
Andrew Von EschenbachAndrew Von EschenbachBoard Member
Jim BertolinaJim BertolinaCo-Founder
Jim AdoxJim AdoxBoard Member
Christine GibbonsChristine GibbonsCo-Founder

Erica Rogers's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Erica Rogers

Dani GolanDani GolanBoard Member · KaminarioDaniel J. MelingerDaniel J. MelingerCEO · KamidaTomer MekhtyTomer MekhtyBoard Member · KaminarioSujeesh KrishnanSujeesh KrishnanCEO · KinnamiAlex KonanykhineAlex KonanykhineCEO · Stock4ServicesRoger EvansRoger EvansBoard Member · Picarro